This inventor holds 4 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignee: Neuro-Bio Ltd. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Sara Garcia-Rates: Innovator in Neurodegenerative Disorders and Cancer Treatment
Introduction
Sara Garcia-Rates is a prominent inventor based in Abingdon, GB. She has made significant contributions to the fields of neurodegenerative disorders and cancer treatment. With a total of 4 patents to her name, her work is paving the way for innovative therapies and diagnostic methods.
Latest Patents
Among her latest patents, one focuses on modified peptides for use in treating neurodegenerative disorders. This invention relates specifically to novel peptides, peptidomimetics, compositions, therapies, and methods for treating conditions such as Alzheimer's disease. Another significant patent addresses cancer, particularly through novel pharmaceutical compositions, therapies, and methods for treating, preventing, or ameliorating cancer, especially metastatic disease. This invention also encompasses diagnostic and prognostic methods for cancer and metastatic disease, along with biomarkers for these conditions.
Career Highlights
Sara Garcia-Rates is currently associated with Neuro-bio Ltd, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving patient outcomes through scientific discovery and application.
Collaborations
Sara collaborates with notable colleagues, including Susan Adele Greenfield and Paul Morrill, who contribute to her research endeavors.
Conclusion
Sara Garcia-Rates is a trailblazer in the fields of neurodegenerative disorders and cancer treatment, with her innovative patents reflecting her dedication to advancing medical science. Her contributions are vital in the ongoing fight against these challenging health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile